Treatment recommendations for psoriatic arthritis
…, A Kavanaugh, DD Gladman, PJ Mease… - Annals of the …, 2009 - ard.bmj.com
Objective: To develop comprehensive recommendations for the treatment of the various
clinical manifestations of psoriatic arthritis (PsA) based on evidence obtained from a systematic …
clinical manifestations of psoriatic arthritis (PsA) based on evidence obtained from a systematic …
2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis
…, J Lin, P Marchetta, PJ Mease… - Journal of Psoriasis …, 2019 - journals.sagepub.com
Objective: To develop an evidence-based guideline for the pharmacologic and nonpharmacologic
treatment of psoriatic arthritis (PsA), as a collaboration between the American College …
treatment of psoriatic arthritis (PsA), as a collaboration between the American College …
[HTML][HTML] Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
…, E Lubrano, LD Mazzuoccolo, PJ Mease… - Nature Reviews …, 2022 - nature.com
Since the second version of the Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …
Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial
PJ Mease, BS Goffe, J Metz, A VanderStoep, B Finck… - The Lancet, 2000 - thelancet.com
… PJ Mease, BS Goffe, J Metz, A VanderStoep, and B Finck contributed to the protocol design.
Additionally, PJ Mease was principal investigator of the study and did the rheumatology …
Additionally, PJ Mease was principal investigator of the study and did the rheumatology …
Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial
…, EC Keystone, DE Furst, PJ Mease… - Annals of internal …, 1999 - acpjournals.org
Background: In a phase II study, etanercept (recombinant human tumor necrosis factor
receptor [p75]:Fc fusion protein) safely produced rapid, dose-dependent improvement in …
receptor [p75]:Fc fusion protein) safely produced rapid, dose-dependent improvement in …
2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria
…, DL Goldenberg, W Häuser, RL Katz, PJ Mease… - Seminars in arthritis and …, 2016 - Elsevier
Objectives The provisional criteria of the American College of Rheumatology (ACR) 2010
and the 2011 self-report modification for survey and clinical research are widely used for …
and the 2011 self-report modification for survey and clinical research are widely used for …
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double‐blind, randomized, placebo‐controlled trial
PJ Mease, DD Gladman, CT Ritchlin… - … : Official Journal of …, 2005 - Wiley Online Library
… Mease has received consulting fees or honoraria of less than $10,000 per year from Abbott.
Dr. Ritchlin has received consulting fees or honoraria of less than $10,000 per year from …
Dr. Ritchlin has received consulting fees or honoraria of less than $10,000 per year from …
Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression
PJ Mease, AJ Kivitz, FX Burch, EL Siegel… - … : Official Journal of …, 2004 - Wiley Online Library
Objective Etanercept has been shown to improve the articular and cutaneous manifestations
of psoriatic arthritis (PsA). In this study, we further evaluated the safety, efficacy, and effect …
of psoriatic arthritis (PsA). In this study, we further evaluated the safety, efficacy, and effect …
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double‐blind, placebo‐controlled trial
LJ Crofford, MC Rowbotham, PJ Mease… - Arthritis & …, 2005 - Wiley Online Library
… Mease has received consulting fees of less than $10,000 from Pfizer, Cypress Bioscience,
Eli Lilly & Co., and Pierre Fabre and owns stock in Cypress Bioscience. Dr. Dworkin has …
Eli Lilly & Co., and Pierre Fabre and owns stock in Cypress Bioscience. Dr. Dworkin has …
Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis
LC Coates, A Kavanaugh, PJ Mease… - Arthritis & …, 2016 - Wiley Online Library
… Mease has received consulting fees, speaking fees, and/or honoraria from Celgene,
Crescendo, the Consortium of Rheumatology Researchers of North America (CORRONA), …
Crescendo, the Consortium of Rheumatology Researchers of North America (CORRONA), …